Theodore R. Schroeder - 06 Sep 2021 Form 4 Insider Report for Nabriva Therapeutics plc (NBRVF)

Role
Chief Executive Officer, Director
Signature
/s/ Theodore R. Schroeder
Issuer symbol
NBRVF
Transactions as of
06 Sep 2021
Transactions value $
-$250
Form type
4
Filing time
08 Sep 2021, 17:27:25
Previous filing
02 Sep 2021
Next filing
15 Sep 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NBRVF Ordinary Shares Tax liability -$250 -225 -0.13% $1.11 177K 06 Sep 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These ordinary shares were withheld by the Issuer in order to satisfy tax withholding obligations upon the vesting of certain restricted share units.